Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study.
Pristipino C, Trani C, Nazzaro MS, Berni A, Patti G, Patrizi R, Pironi B, Mazzarotto P, Gioffrè G, Biondi-Zoccai GG, Richichi G; Prospective REgistry of Vascular Access in Interventions in Lazio Region Study Group. Pristipino C, et al. Among authors: patti g. Heart. 2009 Mar;95(6):476-82. doi: 10.1136/hrt.2008.150714. Epub 2008 Nov 26. Heart. 2009. PMID: 19036757
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators. Pasceri V, et al. Among authors: patti g. Circulation. 2004 Aug 10;110(6):674-8. doi: 10.1161/01.CIR.0000137828.06205.87. Epub 2004 Jul 26. Circulation. 2004. PMID: 15277322 Clinical Trial.
Prevention of myocardial damage during coronary intervention.
Pasceri V, Patti G, Di Sciascio G. Pasceri V, et al. Among authors: patti g. Cardiovasc Hematol Disord Drug Targets. 2006 Jun;6(2):77-83. doi: 10.2174/187152906777441858. Cardiovasc Hematol Disord Drug Targets. 2006. PMID: 16787193 Clinical Trial.
Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
Di Sciascio G, Patti G, Pasceri V, Colonna G, Mangiacapra F, Montinaro A; ARMYDA-4 RELOAD Investigators. Di Sciascio G, et al. Among authors: patti g. Eur Heart J. 2010 Jun;31(11):1337-43. doi: 10.1093/eurheartj/ehq081. Epub 2010 Apr 2. Eur Heart J. 2010. PMID: 20363764 Clinical Trial.
584 results